332 related articles for article (PubMed ID: 34095758)
1. Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments.
Audia S; Mahévas M; Nivet M; Ouandji S; Ciudad M; Bonnotte B
Hemasphere; 2021 Jun; 5(6):e574. PubMed ID: 34095758
[TBL] [Abstract][Full Text] [Related]
2. Emerging Therapies in Immune Thrombocytopenia.
Audia S; Bonnotte B
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33801294
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of immune thrombocytopenia.
Audia S; Mahévas M; Samson M; Godeau B; Bonnotte B
Autoimmun Rev; 2017 Jun; 16(6):620-632. PubMed ID: 28428120
[TBL] [Abstract][Full Text] [Related]
4. Platelet desialylation and TFH cells-the novel pathway of immune thrombocytopenia.
Chen Y; Hu J; Chen Y
Exp Hematol Oncol; 2021 Mar; 10(1):21. PubMed ID: 33722280
[TBL] [Abstract][Full Text] [Related]
5. [Immune thrombocytopenia: From pathogenesis to treatment].
Audia S; Mahevas M; Bonnotte B
Rev Med Interne; 2021 Jan; 42(1):16-24. PubMed ID: 32741715
[TBL] [Abstract][Full Text] [Related]
6. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia.
Li J; van der Wal DE; Zhu G; Xu M; Yougbare I; Ma L; Vadasz B; Carrim N; Grozovsky R; Ruan M; Zhu L; Zeng Q; Tao L; Zhai ZM; Peng J; Hou M; Leytin V; Freedman J; Hoffmeister KM; Ni H
Nat Commun; 2015 Jul; 6():7737. PubMed ID: 26185093
[TBL] [Abstract][Full Text] [Related]
7. Immune thrombocytopenia: a review on the pathogenetic role of immune cells.
Nokhostin F; Bakhshpour F; Pezeshki SMS; Khademi R; Saki N
Expert Rev Hematol; 2023; 16(10):731-742. PubMed ID: 37668243
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia.
Rogier T; Samson M; Mourey G; Falvo N; Magy-Bertrand N; Ouandji S; Picque JB; Greigert H; Mausservey C; Imbach A; Ghesquière T; Voillat L; Caillot D; Deconinck E; Bonnotte B; Audia S
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32630482
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in treatments of adult immune thrombocytopenia.
Kim DS
Blood Res; 2022 Apr; 57(S1):112-119. PubMed ID: 35483935
[TBL] [Abstract][Full Text] [Related]
10. Emerging Concepts in Immune Thrombocytopenia.
Swinkels M; Rijkers M; Voorberg J; Vidarsson G; Leebeek FWG; Jansen AJG
Front Immunol; 2018; 9():880. PubMed ID: 29760702
[TBL] [Abstract][Full Text] [Related]
11. [Research Progress of Desialylation in Immune Thrombocytopenia -Review].
Ma JY; Chen ZP; Gu H; Fu LL; Wu RH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):928-932. PubMed ID: 29950245
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP).
Kapur R; Aslam R; Speck ER; Rebetz JM; Semple JW
Platelets; 2020; 31(3):399-402. PubMed ID: 31146647
[TBL] [Abstract][Full Text] [Related]
13. Platelet destruction in immune thrombocytopenia. Understanding the mechanisms.
Bakchoul T; Sachs UJ
Hamostaseologie; 2016 Aug; 36(3):187-94. PubMed ID: 25982994
[TBL] [Abstract][Full Text] [Related]
14. Immune attack on megakaryocytes in immune thrombocytopenia.
Petito E; Gresele P
Res Pract Thromb Haemost; 2024 Jan; 8(1):102345. PubMed ID: 38525349
[TBL] [Abstract][Full Text] [Related]
15. Novel therapies for immune thrombocytopenia.
Kuter DJ
Br J Haematol; 2022 Mar; 196(6):1311-1328. PubMed ID: 34611885
[TBL] [Abstract][Full Text] [Related]
16. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
Gernsheimer TB
Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
[TBL] [Abstract][Full Text] [Related]
17. CD8(+) T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia.
Qiu J; Liu X; Li X; Zhang X; Han P; Zhou H; Shao L; Hou Y; Min Y; Kong Z; Wang Y; Wei Y; Liu X; Ni H; Peng J; Hou M
Sci Rep; 2016 Jun; 6():27445. PubMed ID: 27321376
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of Autoimmune Thrombocytopenia: Current Insight with a Focus on Thrombopoiesis.
Marini I; Bakchoul T
Hamostaseologie; 2019 Aug; 39(3):227-237. PubMed ID: 30802916
[TBL] [Abstract][Full Text] [Related]
19. Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia.
Tao L; Zeng Q; Li J; Xu M; Wang J; Pan Y; Wang H; Tao Q; Chen Y; Peng J; Hou M; Jansen AJ; Ni H; Zhai Z
J Hematol Oncol; 2017 Feb; 10(1):46. PubMed ID: 28179000
[TBL] [Abstract][Full Text] [Related]
20. Recognition of the human antibody-mediated platelet destruction in adult ITP patients by C-reactive protein.
Pan JQ; Wang W; Wang ML; Li XY; Wang JH; Zhao WW; Tian YY; Dong XS; Jiang YF
Int J Clin Exp Pathol; 2017; 10(10):10176-10185. PubMed ID: 31966351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
